Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Rank in Stocks #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Share Price
$0.0001
Last synced: 2023-05-22
Market Cap
$10.03K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade NuGenerex Immuno-Oncology, Inc. (NUGX)

Category

Stock price history for NuGenerex Immuno-Oncology, Inc. (NUGX)
Highest end of day price: $0.00 on 2023-05-01

Lowest end of day price: $1.44 on 2021-03-01
Stock price history of NuGenerex Immuno-Oncology, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2023 75.00%
2022 -98.81%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.52%
KR